Circulogene Theranostics

CIRCULOGENE also offers testing of Hereditary (Germline) mutations passed on from parents to offspring. These inherited germline mutations play an important rol

The page says uncertainty about next steps in the diagnostic journey can cause anxiety and fear for patients and clinicians.

Circulogene is pleased to offer OncoGenDx, a validated, multi-modal tumor profiling solution. This comprehensive tissue-based CGP platform builds on the success

CIRCULOGENE announced the launch of its improved Somatic NGS & Molecular Test.

CIRCULOGENE combines talent and laboratory equipment.

Mike Mullen has more than 25 years in executive and financial leadership and has been involved in over $200M in liquidity and capital transactions. Before founding CIRCULOGENE in 2015, he was President and CEO of Atherotech Diagnostics.

CIRCULOGENE has a leadership team.

Dr. Paul Walker held oncology leadership roles at East Carolina University and the Brody School of Medicine and published articles on cancer biotherapy for breast and lung cancers.

Cancer today continues to be a tremendous burden on America’s healthcare system. According to the American Society of Clinical Oncology, 1.8 million people are

CIRCULOGENE has laboratories in Birmingham, AL, and Pensacola, FL, and describes its tests as CAP- and CLIA-certified laboratory-developed tests.

For Asia Pacific inquiries, please email AsiaPacfic@circulogene.com

CIRCULOGENE provides molecular and genomic tests for comprehensive genomic profiling of solid tumors at all stages.

The company’s website is circulogene.com. When visitors leave comments, the company collects the data shown in the comments form.